SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

OMXC 20 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Genmab: Click to view the issuer\'s details

Last update : 25/05/2014  >View issuer details

2018.11.14 | 17:00 | Permanent Information Releases / Sales and Revenues

English version HTML (w) Mail

puce Genmab Announces Financial Results for the First Nine Months of 2018 - HTML (w)

2018.11.08 | 14:57 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab to Present at the Jefferies 2018 London Healthcare Conference - HTML (w)

2018.11.01 | 14:16 | Annual General Meeting / Preparatory Documents

English version HTML (w) Mail

puce Genmab Announces Data to be Presented at 2018 ASH Annual Meeting - HTML (w)

2018.10.16 | 12:45 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2018 - HTML (w)

2018.10.09 | 00:51 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab and Seattle Genetics Announce Tisotumab Vedotin Data to be Presented at ESMO 2018 Congress - HTML (w)

2018.09.26 | 07:24 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab’s 2018 Capital Markets Day - HTML (w)

2018.09.25 | 09:02 | Permanent Information Releases / Calendar

English version HTML (w) Mail

puce Genmab's Financial Calendar for 2019 - HTML (w)

2018.09.21 | 21:16 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Grant of Restricted Stock Units and Warrants to Genmab employees - HTML (w)

2018.09.19 | 14:59 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab to Host Capital Markets Day - HTML (w)

2018.09.18 | 18:16 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Capital Increase in Genmab as a Result of Employee Warrant Exercise - HTML (w)

2018.09.06 | 15:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab to Present at Morgan Stanley 16th Annual Global Healthcare Conference - HTML (w)

2018.08.31 | 14:35 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Front Line Multiple Myeloma - HTML (w)

2018.08.14 | 19:08 | Permanent Information Releases / Operations

English version HTML (w) Mail

puce Capital Increase in Genmab as a Result of Employee Warrant Exercise - HTML (w)

2018.08.09 | 18:18 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Major Shareholder Announcement - HTML (w)

Pages : 1 - 2 - 3 - 4 / Doc nb : 58